Stock Analysis of MyMD Pharmaceuticals Inc (MYMD) - Birds Eye View

1W   2W   1M   3M   1Y   2Y   5Y   
Overview
Code MYMD
Close 1.86
Change -0.120 / 6.06 %
Volume 502413
Vol Change -358930.00 / 41.67 %
IndustryBiotechnology
SectorHealthcare
AIO Strength Index
Technical StrengthStrong Bearish
Growth Index Low Growth Stock
Value Index Very Low Value Stock
Profitability Index Poor Profitability Stock
Stability Index Poor Stability Stock


Fundamental View of MyMD Pharmaceuticals Inc
PE (TTM)

-0.515

Very Poor
Price / Book

0.457

Excellent
Price / Sales

0

Very Poor
Piotroski F Score

2.0

Poor
Market Cap

4292.19 K

Enterprise Value

17321.69 K

ROA (TTM)

-38.36

Very Poor
ROE (TTM)

-47.20

Very Poor
Net Margin (TTM)

0

Poor
Revenue

%

0
Net Profit

64.39 %

-5381.91 K
Debt to Equity

-0.545

Very Poor
Altman Z Score

12.80

Excellent
Quick Ratio

0

Poor
Cash Ratio

-2.60

Very Poor


Highs/Lows of MyMD Pharmaceuticals Inc
PeriodOld priceStock ReturnS&P 500 ReturnsHighLowHigh DateLow Date
One Week2.0 7.00 % 0.513 % 2.061.831-May-2431-May-24
Two Week2.35 20.85 % 0.486 % 2.4451.820-May-2431-May-24
One Month3.08 39.61 % 4.80 % 3.36691.803-May-2431-May-24
Three Month3.43 45.77 % 3.56 % 3.59991.811-Mar-2431-May-24
Six Months8.4 77.86 % 15.54 % 10.6651.827-Dec-2331-May-24
One year52.2 96.44 % 26.26 % 63.871.803-Aug-2331-May-24
Two year90.3 97.94 % 27.72 % 89.41.802-Feb-2331-May-24
Five year852.336 99.78 % 91.77 % 70.50.10822-May-2313-Feb-24
Ten year45008.7 100.00 % 174.36 % 60824.40.10814-Apr-1513-Feb-24


Technical View of MyMD Pharmaceuticals Inc
RSI

31.45

Neutral
MACD

-0.210

Bearish
ADX

19.50

Neutral
Super Trend

2.44

Mild Bearish
Williams %R

-92.50

Mild Bullish
CCI

-94.93

Neutral


EMA 5

1.96

Strong Bearish
EMA 15

2.16

Strong Bearish
EMA 50

2.67

Strong Bearish
EMA 100

4.57

Strong Bearish
SMA 100

3.29

Strong Bearish
SMA 200

8.93

Mild Bearish
SMA 5 / 20

1.97 / 2.33

Mild Bearish
SMA 15 / 50

2.15 / 2.47

Strong Bearish
SMA 50 / 200

2.47 / 8.93

Mild Bearish




Charts of MyMD Pharmaceuticals Inc


Returns of MyMD Pharmaceuticals Inc with Peers
Period / StockMYMDENSCPTPIISPC
1 Week-7.00%0.877%0.689%39.62%
1 Mth-39.61%-2.81%-9.14%47.73%
3 Mth-45.77%-38.33%-64.29%-4.47%
6mth-77.86%-49.56%-61.61%-23.22%
1 Year-96.44%-75.74%-73.64%-67.68%
2 Year-97.94%-99.57%-93.70%-85.67%
5 Years-99.78%-99.98%--
charts-
View All Together in Chart      Inline           Tile

Compare Fundamentals of MyMD Pharmaceuticals Inc with Peers
Ratio / StockMYMDENSCPTPIISPC
PE-0.515-0.166-0.0460-0.334
P/B0.4571.260.04600.314
ROA-38.36-271.39-36.10-69.43
ROE-47.20-650.98-100.36-94.14
Debt To Equity-0.545-1.310.00070.0172
Revenue0
% 		2230.52 K
11.61 % 		6984.74 K
16.57 % 		9928.18 K
4.56 %
Net Income-5381.91 K
64.39 % 		-12599.98 K
49.77 % 		-12702.70 K
53.02 % 		-11099.49 K
8.33 %


Technicals of MyMD Pharmaceuticals Inc with Peers
Technical / StockMYMDENSCPTPIISPC-
ADX19.5022.7316.6248.78
CMF-0.2890.204-0.468-0.0209
MFI45.8565.1450.2269.92
RSI31.4544.5741.6968.61
MACD Abv SignalFalseTrueTrueTrue
Price Above 50 MAFalseFalseFalseTrue-
Price Above 200 MAFalseFalseFalseFalse-


About : MyMD Pharmaceuticals Inc

Address : 855 North Wolfe Street, Baltimore, MD, United States, 21205
Tel : 856 848 8698
URL : https://www.mymd.com
Code : MYMD, ISIN : US62856X1028, Exchange : NASDAQ, Country : USA
Fiscal Year End : December
IPO date : 23_Jan_2014
Employee Count : 6

MyMD Pharmaceuticals, Inc., a clinical development stage pharmaceutical company, focuses on developing various therapeutic platforms to treat the aging and age-related and autoimmune diseases, and chronic pain, anxiety, and sleep disorders. The company is developing MYMD-1, a drug platform based on a clinical stage small molecule that regulates the immunometabolic system and its pro-inflammatory cytokines to treat autoimmune diseases and age-related illnesses, and a Phase 2 clinical trial for multiple sclerosis, diabetes, inflammatory bowel diseases, and rheumatoid arthritis. It is also developing Supera-CBD, a synthetic analog of cannabidiol for treating epilepsy, pain, and anxiety/depression. The company was founded in 2014 and is headquartered in Baltimore, Maryland.


Note : All Data Generated at the End of Trading Hours (EOD Data)